Back
Candel Therapeutics Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Buy
61
CADL
Candel Therapeutics
Last Price:
$9.17
Seasonality Move:
-4.03%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CADL is experiencing buying pressure, which is a positive indicator for future bullish movement.
Candel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.07 | Buy |
| 20-day SMA: | 6.59 | Buy |
| 50-day SMA: | 5.66 | Buy |
| 200-day SMA: | 6.21 | Buy |
| 8-day EMA: | 8.28 | Buy |
| 20-day EMA: | 7.09 | Buy |
| 50-day EMA: | 6.22 | Buy |
| 200-day EMA: | 5.52 | Buy |
Candel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.04 | Buy |
| Relative Strength Index (14 RSI): | 62.67 | Buy |
| Chaikin Money Flow: | 1316317 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.25 - 8.09) | Buy |
| Bollinger Bands (100): | (4.74 - 7.2) | Buy |
Candel Therapeutics Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Candel Therapeutics Stock
Is Candel Therapeutics Stock a Buy?
-
Candel Therapeutics share price is 9.17 while CADL 8-day simple moving average is 8.07, which is a Buy signal.
-
The stock price of CADL is 9.17 while Candel Therapeutics 20-day SMA is 6.59, which makes it a Buy.
-
Candel Therapeutics 50-day simple moving average is 5.66 while CADL share price is 9.17, making it a Buy technically.
-
CADL stock price is 9.17 and Candel Therapeutics 200-day simple moving average is 6.21, creating a Buy signal.
CADL Technical Analysis vs Fundamental Analysis
Buy
61
Candel Therapeutics (CADL)
is a Buy
Is Candel Therapeutics a Buy or a Sell?
-
Candel Therapeutics stock is rated a BuyThe current Candel Therapeutics [CADL] share price is $9.17. The Score for CADL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Candel Therapeutics Stock Info
Market Cap:
297.8M
Price in USD:
9.17
Share Volume:
1.9M
Candel Therapeutics 52-Week Range
52-Week High:
14.60
52-Week Low:
1.16
Buy
61
Candel Therapeutics (CADL)
is a Buy
Candel Therapeutics Share Price Forecast
-
What is the Candel Therapeutics stock price today?The Candel Therapeutics stock price is 9.17 USD today.
-
Will CADL stock go up or go down?Candel Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Candel Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Candel Therapeutics is not overvalued.
Is Candel Therapeutics Stock a Buy?
-
Candel Therapeutics share price is 9.17 while CADL 8-day exponential moving average is 8.28, which is a Buy signal.
-
The stock price of CADL is 9.17 while Candel Therapeutics 20-day EMA is 7.09, which makes it a Buy.
-
Candel Therapeutics 50-day exponential moving average is 6.22 while CADL share price is 9.17, making it a Buy technically.
-
CADL stock price is 9.17 and Candel Therapeutics 200-day simple moving average is 5.52, creating a Buy signal.
Fundamental Analysis of Candel Therapeutics
Is Candel Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.03 per share.
Technical Analysis of Candel Therapeutics
Should I short Candel Therapeutics stock?
-
CADL Moving Average Covergence Divergence (MACD) indicator is 1.04, suggesting Candel Therapeutics is a Buy
-
Candel Therapeutics Relative Strength Index (RSI) is 62.67, which suggest Candel Therapeutics is overbought
-
The Bollinger Bands (25) for Candel Therapeutics is (4.25 - 8.09), which suggest Candel Therapeutics is a Buy
-
The Bollinger Bands (100) for Candel Therapeutics is (4.74 - 7.2), which suggest Candel Therapeutics is a Buy
* Candel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.